{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-153110","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2022-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.531558+00:00","generated_at":"2026-06-25T11:05:15.958596+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Inovio appoints CEO Shea to board; shareholders approve auditor and exec compensation vote","bullets":["CEO Jacqueline Shea appointed to board following May 16, 2022 annual meeting; term until 2023 annual meeting.","All seven director nominees elected; highest votes for David Weiner (53.2M), lowest for Lota Zoth (48.1M for).","Ratification of Ernst & Young as auditor passed with 109.6M for, 6.7M against, 1.4M abstain.","Advisory 'say-on-pay' vote passed with 40.8M for, 16.9M against, 0.7M abstain; broker non-votes 59.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-153110","json":"https://secwatch.observer/filing/0001193125-22-153110.json","markdown":"https://secwatch.observer/filing/0001193125-22-153110.md","text":"https://secwatch.observer/filing/0001193125-22-153110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312522153110/0001193125-22-153110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312522153110/d338053d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T11:05:15.958596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}